Currently Viewing:
The American Journal of Managed Care August 2014
Personalized Preventive Care Reduces Healthcare Expenditures Among Medicare Advantage Beneficiaries
Shirley Musich, PhD; Andrea Klemes, DO, FACE; Michael A. Kubica, MBA, MS; Sara Wang, PhD; and Kevin Hawkins, PhD
Currently Reading
Impact of Hypertension on Healthcare Costs Among Children
Todd P. Gilmer, PhD; Patrick J. O'Connor, MD, MPH; Alan R. Sinaiko, MD; Elyse O. Kharbanda, MD, MPH; David J. Magid, MD, MPH; Nancy E. Sherwood, PhD; Kenneth F. Adams, PhD; Emily D. Parker, MD, PhD; and Karen L. Margolis, MD, MPH
Potential Role of Network Meta-Analysis in Value-Based Insurance Design
James D. Chambers, PhD, MPharm, MSc; Aaron Winn, MPP; Yue Zhong, MD, PhD; Natalia Olchanski, MS; and Michael J. Cangelosi, MA, MPH
Massachusetts Health Reform and Veterans Affairs Health System Enrollment
Edwin S. Wong, PhD; Matthew L. Maciejewski, PhD; Paul L. Hebert, PhD; Christopher L. Bryson, MD, MS; and Chuan-Fen Liu, PhD, MPH
Contemporary Use of Dual Antiplatelet Therapy for Preventing Cardiovascular Events
Andrew M. Goldsweig, MD; Kimberly J. Reid, MS; Kensey Gosch, MS; Fengming Tang, MS; Margaret C. Fang, MD, MPH; Thomas M. Maddox, MD, MSc; Paul S. Chan, MD, MSc; David J. Cohen, MD, MSc; and Jersey Chen, MD, MPH
Potential Benefits of Increased Access to Doula Support During Childbirth
Katy B. Kozhimannil, PhD, MPA; Laura B. Attanasio, BA; Judy Jou, MPH; Lauren K. Joarnt; Pamela J. Johnson, PhD; and Dwenda K. Gjerdingen, MD
Synchronization of Coverage, Benefits, and Payment to Drive Innovation
Annemarie V. Wouters, PhD; and Nancy McGee, JD, DrPH
The Effect of Depression Treatment on Work Productivity
Arne Beck, PhD; A. Lauren Crain, PhD; Leif I. Solberg, MD; Jürgen Unützer, MD, MPH; Michael V. Maciosek, PhD; Robin R. Whitebird, PhD, MSW; and Rebecca C. Rossom, MD, MSCR
Economic Implications of Weight Change in Patients With Type 2 Diabetes Mellitus
Kelly Bell, MSPhr; Shreekant Parasuraman, PhD; Manan Shah, PhD; Aditya Raju, MS; John Graham, PharmD; Lois Lamerato, PhD; and Anna D'Souza, PhD
Optimizing Enrollment in Employer Health Programs: A Comparison of Enrollment Strategies in the Diabetes Health Plan
Lindsay B. Kimbro, MPP; Jinnan Li, MPH; Norman Turk, MS; Susan L. Ettner, PhD; Tannaz Moin, MD, MBA, MSHS; Carol M. Mangione, MD; and O. Kenrik Duru, MD, MSHS
Does CAC Testing Alter Downstream Treatment Patterns for Cardiovascular Disease?
Winnie Chia-hsuan Chi, MS; Gosia Sylwestrzak, MA; John Barron, PharmD; Barsam Kasravi, MD, MPH; Thomas Power, MD; and Rita Redberg MD, MSc
Effects of Multidisciplinary Team Care on Utilization of Emergency Care for Patients With Lung Cancer
Shun-Mu Wang, MHA; Pei-Tseng Kung, ScD; Yueh-Hsin Wang, MHA; Kuang-Hua Huang, PhD; and Wen-Chen Tsai, DrPH
Health Economic Analysis of Breast Cancer Index in Patients With ER+, LN- Breast Cancer
Gary Gustavsen, MS; Brock Schroeder, PhD; Patrick Kennedy, BE; Kristin Ciriello Pothier, MS; Mark G. Erlander, PhD; Catherine A. Schnabel, PhD; and Haythem Ali, MD

Impact of Hypertension on Healthcare Costs Among Children

Todd P. Gilmer, PhD; Patrick J. O'Connor, MD, MPH; Alan R. Sinaiko, MD; Elyse O. Kharbanda, MD, MPH; David J. Magid, MD, MPH; Nancy E. Sherwood, PhD; Kenneth F. Adams, PhD; Emily D. Parker, MD, PhD; and Karen L. Margolis, MD, MPH
This study demonstrates a major influence of prehypertension and hypertension on healthcare costs in a large cohort of children, independent of body mass index.
Table 3 shows that the standardized cost differentials between categories narrowed when controlling for additional comorbidity using the CDPS score. The differential in total costs between HT and normotensive children declined by $383 (SE = $90) to $852 (SE = $53), and the cost differential between preHT and normotensive children declined by $67 (SE = $18) to $141 (SE = $9) (P <.001 each) when adjusting for additional comorbidity using CDPS. The differentials in total cost for children above the 95th percentile of BMI and children between the 85th and 95th percentiles compared to children below the 85th percentile declined by $67 (SE = $19, P <.001) and $64 (SE = $48, P = .192), respectively, to $48 (SE = $11, P <.001) and $68 (SE = $15, P <.001) when adjusting for additional comorbidity using CDPS.

Table 4 shows estimates of outpatient utilization associated with preHT and HT. There were statistically significant increases in all measures of utilization except for laboratory testing. Utilization was at least 50% higher in HT than normal BP children in all categories, except for laboratory testing (P <.001 each), with the large percentage increases observed for renal ultrasound, echocardiogram, and chest x-ray. However, these procedures were performed at a relatively low rate, and all diagnostic and evaluation procedures with the exception of urinalysis were conducted in fewer than 10% of children with HT. We reviewed the types of specialist consultations, but could not identify any specific pattern to differentiate visits among the BP categories.


The present study shows the strong incremental effects of both preHT and HT, independent of BMI and comorbidity, on healthcare costs in children. Although BMI status also was significantly associated with cost, the major influence on cost in this large cohort of children was BP status. It should be noted that the percent of children with preHT was higher than previously reported.38 Because the definition for preHT requires only a single BP measurement, the requirement of 3 separate clinic BP measurements for inclusion in this study increased the number with preHT.

An important factor in this analysis is that hypertension was identified primarily from review of EHRs, with only 17% recognized by the clinic physicians. The lack of recognition of HT by providers using computerized medical record systems has been reported previously,39 as has the extent of the underrecognition.40 However, there was no significant difference in cost associated with the EHR method, as opposed to physician recognition and diagnosis. Thus, there may be something inherent in the presence of hypertension or prehypertension that leads to increased outpatient and emergency department visits, specialist consultations, increased diagnostic and evaluation procedures, and their associated costs; or medical issues resulting in more frequent clinic visits with greater number of BP measurements resulting in a larger number of diagnoses of preHT or HT. This may account for the significantly greater use of cardiac studies and chest x-rays in the subjects with hypertension.

Elevated BP in adults has been shown to be associated with substantial increased costs in 3 national data sets.41-43 Studies of adults have further shown that both obesity and hypertension are independent determinants of costs.44 In contrast, little attention has been devoted to the costs or to strategies to address elevated BP in children or adolescents. Given the strong relationship between elevated BP and healthcare costs, a case could be made to health plans and payers to consider implementing strategies to manage healthcare utilization of children with elevated BP. These strategies might include improved primary care, case management, health behavior interventions, family education, or other interventions.45-47

In contrast to prior studies, costs of healthcare services in this study were not significantly different between overweight (BMI ≥85th percentile to < 95th percentile) and obese (BMI ≥95th percentile) children controlling for BP status. Studies assessing healthcare utilization and cost related to overweight or obesity previously have not been able to adjust for BP status due to lack of BP data. By including both BMI and BP status in the analyses, this study has been able to extend previous findings by showing that the effect of BMI is lower than previously reported and is confounded by the associated impact of preHT and HT.

These findings are relevant to ongoing clinical and public policy discussions. First, they suggest that greater attention should be paid to elevated BP in children and adolescents as a driver of healthcare costs. Second, elevated BP has a significant effect on cost independent from elevated BMI and other comorbid conditions. Third, studies that do not account for the impact of BP level on utilization may overestimate the effect of BMI on utilization and costs.

There are limitations that should be considered in the interpretation of these data. First, despite the large, racially and ethnically diverse study population, these results may not be generalizable to costs of care in non–insurance-driven healthcare systems. However, it is currently challenging to conduct this type of study and capture detailed clinical and cost data outside the highly integrated healthcare systems included in this study. Second, it is possible that some allopathic care was obtained outside the insurance system, although prior studies suggest that this is well under 5% of total allopathic care. Third, although we adjusted for comorbidity using CDPS, there may be some residual differences in comorbidities by BP status. Finally, the results from this study do not imply causality between hypertension and the increased cost of patient care. However, the data clearly show an association between BP and healthcare costs in youth.

In summary, this study provides for the first time an estimate of the impact of BP and BMI status on healthcare utilization and cost in children and adolescents. Results suggest that costs attributable to overweight or obesity may be systematically overestimated in studies that do not adjust for BP status, and that BP status has a major independent association with utilization and costs of healthcare in youth. While we do not have the data to examine whether lowering BP in those with elevated BP would reduce their healthcare cost, it seems reasonable to suggest this may occur.

Author Affiliations: Department of Family and Preventive Medicine, University of California, San Diego (TPG); HealthPartners Institute for Education and Research, Minneapolis, MN (PJO, EOK, NES, KFA, KLM); Department of Pediatrics, University of Minnesota, Minneapolis (ARS); Institute for Health Research, Kaiser Permanente Colorado, Denver (DJM).

Funding Source: Funding was provided by the National Institutes of Health grant R01HL093345 from the National Heart, Lung, and Blood Institute.
Author Disclosures:
The authors report no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this article.

Authorship Information: Concept and design (TPG, PJO, ARS, EOK, KLM); acquisition of data (PJO, KLM); analysis and interpretation of data (TPG, PJO, ARS, EOK, DJM, NES, KFA, EDP, KLM); drafting of the manuscript (TPG, PJO, ARS); critical revision of the manuscript for important intellectual content (TPG, PJO, ARS, EOK, DJM, NES, KFA, EDP, KLM); statistical analysis (TPG); provision of study materials or patients (PJO); obtaining funding (PJO, ARS, NES); administrative, technical, or logistic support (TPG); supervision (TPG, POC).

Address correspondence to: Todd Gilmer, PhD, Department of Family and Preventive Medicine, University of California, San Diego, 9500 Gilman Dr, La Jolla, CA 92092-0622. E-mail:
1. Daniels SR. Cardiovascular sequelae of childhood hypertension. Am J Hypertens. 2002;15(2, pt 2):61S-63S.

2. Mitchell P, Cheung N, de Haseth K, et al. Blood pressure and retinal arteriolar narrowing in children. Hypertension. 2007;49(5):1156-1162.

3. Raitakari OT, Juonala M, Kähönen M, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA. 2003;290(17):2277-2283.

4. Donahue RP, Prineas RJ, Gomez O, Hong CP. Tracking of elevated systolic blood pressure among lean and overweight adolescents: the Minneapolis Children’s Blood Pressure Study. J Hypertens.1994;12(3):303-308.

5. Klumbiene J, Sileikiene L, Milasauskiene Z, Zaborskis A, Shatchkute A. The relationship of childhood to adult blood pressure: longitudinal study of juvenile hypertension in Lithuania. J Hypertens. 2000;18(5):531-538.

6. Elkasabany AM, Urbina EM, Daniels SR, Berenson GS. Prediction of adult hypertension by K4 and K5 diastolic blood pressure in children: the Bogalusa Heart Study. J Pediatr. 1998;132(4):687-692.

7. Lauer RM, Burns TL, Clarke WR, Mahoney LT. Childhood predictors of future blood pressure. Hypertension. 1991;18(suppl):174-181.

8. Yong LC, Kuller LH. Tracking of blood pressure from adolescence to middle age: the Dormont High School Study. Prev Med. 1994;23(4):418-426.

9. Sinaiko AR, Donahue RP, Jacobs DR Jr, Prineas RJ. Relation of weight and rate of increase in weight during childhood and adolescence to body size, blood pressure, fasting insulin, and lipids in young adults: the Minneapolis Children’s Blood Pressure Study. Circulation. 1999;99(11):1471-1476.

10. Chiolero A, Bovet P, Paradis G, Paccaud F. Has blood pressure increased in children in response to the obesity epidemic? Pediatrics. 2007;119(3):544-553.

11. Muntner P, He J, Cutler JA, Wildman RP, Whelton PK. Trends in blood pressure among children and adolescents. JAMA. 2004;291(17):2107-2113.

12. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(suppl 4th Report):555-576.

13. McNiece KL, Poffenbarger TS, Turner JL, Franco KD, Sorof JM, Portman RJ. Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr. 2007;150(6):640-644, 644.e1.

14. Fuentes RM, Notkola IL, Shemeikka S, Tuomilehto J, Nissinen A. Tracking of systolic blood pressure during childhood: a 15-year followup population-based family study in eastern Finland. J Hypertens. 2002;20(2):195-202.

15. Vos LE, Oren A, Uiterwaal C, Gorissen WH, Grobbee DE, Bots ML. Adolescent blood pressure and blood pressure tracking into young adulthood are related to subclinical atherosclerosis: the Atherosclerosis Risk in Young Adults (ARYA) study. Am J Hypertens. 2003;16(7):549-555.

16. Wang YC, Cheung AM, Bibbins-Domingo K, et al. Effectiveness and cost-effectiveness of blood pressure screening in adolescents in the United States. J Pediatr. 2011;158(2):257-264.

17. Tran CL, Ehrmann BJ, Messer KL, et al. Recent trends in healthcare utilization among children and adolescents with hypertension in the United States. Hypertension. 2012;60(2):296-302.

18. Samuels J. The increasing burden of pediatric hypertension. Hypertension. 2012;60(2):276-277.

19. Elliott DJ, Weintraub WS. Population-based health requires population-based change. J Pediatr. 2011;158(2):181-184.

20. Hampl SE, Carroll CA, Simon SD, Sharma V. Resource utilization and expenditures for overweight and obese children. Arch Pediatr Adolesc Med.2007;161(1):11-14.

21. Finkelstein EA, Fiebelkorn IC, Wang G. State-level estimates of annual medical expenditures attributable to obesity. Obes Res. 2004;12(1):18-24.

22. Thorpe KE, Florence CS, Howard DH, Joski P. The impact of obesity on rising medical spending. Health Aff (Millwood). 2004;Suppl Web Exclusives:W4-480-486.

23. Wang G, Dietz WH. Economic burden of obesity in youths aged 6 to 17 years: 1979-1999. Pediatrics. 2002;109(5):E81.

24. O’Brien SH, Holubkov R, Reis EC. Identification, evaluation, and management of obesity in an academic primary care center. Pediatrics. 2004;114(2):e154-e159.

25. Finkelstein EA, Fiebelkorn IC, Wang G. National medical spending attributable to overweight and obesity: how much, and who’s paying? Health Aff (Millwood). 2003;Suppl Web Exclusives:W3-219-226.

26. Gilmer TP, O’Connor PJ, Rush WA, et al. Predictors of health care costs in adults with diabetes. Diabetes Care. 2005;28(1):59-64.

27. Gilmer TP, O’Connor PJ, Rush WA, et al. Impact of office systems and improvement strategies on costs of care for adults with diabetes. Diabetes Care. 2006;29(6):1242-1248.

28. Kronick R, Gilmer T, Dreyfus T, Lee L. Improving health-based payment for Medicaid beneficiaries: CDPS. Health Care Financ Rev. 2000;21(3):29-64.

29. Manning WG, Newhouse JP, Duan N, Keeler EB, Leibowitz A, Marquis MS. Health insurance and the demand for medical care: evidence from a randomized experiment. Am Econ Rev. 1987;77(3):251-277.

30. Blough DK, Madden CW, Hornbrook MC. Modeling risk using generalized linear models. J Health Econ.1999;18(2):153-171.

31. Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20(4):461-494.

32. Buntin MB, Zaslavsky AM. Too much ado about two-part models and transformation? comparing methods of modeling Medicare expenditures. J Health Econ. 2004;23(3):525-542.

33. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley and Sons; 1989.

34. Pregibon D. Goodness of link tests for generalized linear models. Applied Statistics. 1980; 29:15-24.

35. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York, NY: Chapman & Hall; 1993.

36. Stata Statistical Software [computer program]. Version 12. College Station, TX: StataCorp LP; 2011.

37. Lo JC, Sinaiko A, Chandra M, et al. Prehypertension and hypertension in community-based pediatric practice. Pediatrics. 2013;131(2):e415-e424.

38. Brady TM, Solomon BS, Neu AM, Siberry GK, Parekh RS. Patient-,provider-, and clinic-level predictors of unrecognized elevated blood pressure in children. Pediatrics. 2010;125(6):e1286-e1293.

39. Daley MF, Sinaiko AR, Reifler LM, et al. Patterns of care and persistence after incident elevated blood pressure. Pediatrics. 2013;132(2):e349-e355.

40. Hodgson TA, Cai L. Medical care expenditures for hypertension, its complications, and its comorbidities. Med Care. 2001;39(6):599-615.

41. Balu S, Thomas J III. Incremental expenditure of treating hypertension in the United States. Am J Hypertens. 2006;19(8):810-816; discussion 817.

42. Trogdon JG, Finkelstein EA, Nwaise IA, Tangka FK, Orenstein D. The economic burden of chronic cardiovascular disease for major insurers. Health Prom Pract. 2007;8(3):234-242.

43. Wang G, Zheng ZJ, Heath G, Macera C, Pratt M, Buchner D. Economic burden of cardiovascular disease associated with excess body weight in U.S. adults. Am J Prev Med. 2002;23(1):1-6.

44. Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003;42(5):878-884.

45. Kelley GA, Kelley KS, Tran ZV. The effects of exercise on resting blood pressure in children and adolescents: a meta-analysis of randomized controlled trials. Prev Cardiol. 2003;6(1):8-16.

46. He FJ, MacGregor GA. Importance of salt in determining blood pressure in children: meta-analysis of controlled trials. Hypertension. 2006;48(5):861-869.

47. He FJ, MacGregor GA. Importance of salt in determining blood pressure in children: meta-analysis of controlled trials. Hypertension. 2006;48(5):861-869.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up